Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
12.91
-0.57 (-4.23%)
At close: Nov 2, 2026, 4:00 PM EST
12.91
0.00 (0.00%)
After-hours: Nov 2, 2026, 4:15 PM EST
Crescent Biopharma Employees
Crescent Biopharma had 69 employees as of June 30, 2026. The number of employees increased by 36 or 109.09% compared to the same quarter last year. That makes Crescent Biopharma the 33,543rd largest employer in the world and 4,411th in the United States.
Employees
69
Change (1Y)
36
Growth (1Y)
109.09%
Revenue / Employee
$172,217
Profits / Employee
-$2,393,101
Market Cap
552.56M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Jun 30, 2026 | 69 | 36 | 109.09% |
| Mar 31, 2026 | 55 | 22 | 66.67% |
| Dec 31, 2025 | 44 | - | - |
| Sep 30, 2025 | 41 | - | - |
| Jun 30, 2025 | 33 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| MiMedx Group | 808 |
| Geron | 258 |
| DBV Technologies | 170 |
| Neurogene | 131 |
| Bicara Therapeutics | 103 |
| Zevra Therapeutics | 61 |
| Shattuck Labs | 40 |
| Climb Bio | 29 |
CBIO News
- 10 hours ago - Crescent Biopharma to Present at November Investor Conferences - GlobeNewsWire
- 18 days ago - Crescent Biopharma completes dose escalation in ASCEND trial of CR-001 - TheFly
- 18 days ago - Crescent Biopharma Announces Clinical Pipeline Momentum, including Enrolling Patients in Standard of Care Chemotherapy Combination Cohorts of Global Phase 1/2 ASCEND Trial of CR-001, a PD-1 x VEGF Bispecific Antibody, and Initiation of Additional ADC Combination Studies with CR-001 - GlobeNewsWire
- 27 days ago - Crescent Biopharma Announces Grants of Inducement Awards - GlobeNewsWire
- 27 days ago - Crescent Biopharma upgraded to Buy from Neutral at H.C. Wainwright - TheFly
- 4 weeks ago - Crescent Biopharma announces FDA clearance of CR-002 IND application - TheFly
- 4 weeks ago - Crescent Biopharma Announces FDA Clearance of IND Application for CR-002, a PD-L1-targeted Topoisomerase Inhibitor ADC, for the Treatment of Solid Tumors - GlobeNewsWire
- 7 weeks ago - Crescent Biopharma Transcript: Morgan Stanley 24th Annual Global Healthcare Conference - Transcripts